Tesamorelin 20mg

Tesamorelin 20mg — Research Peptide

Tesamorelin (CAS 218949-48-5) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) — the 44-amino acid hypothalamic peptide that stimulates pituitary GH release. Tesamorelin is FDA-approved as Egrifta for HIV-associated abdominal lipodystrophy, giving it an extensive clinical research foundation.

Research applications include: GH/IGF-1 axis modulation, visceral adipose tissue reduction studies, body composition research, and metabolic regulation. Tesamorelin activates GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release while preserving natural pulsatility and somatostatin feedback. 20mg vial, ≥99% purity, lyophilized. For research purposes only.